prefill jv deal coming, page-8

Which one would you choose:

1. UNI - 1ml safety and insulin syringe in production now
in kdl china, ibs final stages fda imminent.
- prefill verification rollout happening, strong
partners and imminent JV with global players re-
announcement.
- blood collection device

2. RTL - not trading for some time now they were meant to
be competition
3. EMS - clip-on oh yeah that's great, possibly will make
money with artimist but not syringes
4 OMI - another competitive syringe that by the time RTI
have finished with them I don't believe they will
have much money left. RTI have gone up against 2
previous companies and won both 1 being I believe
B&D. not much chance here not a safe bet.
5. MDZ - not much happening there
6. SFP - producing but really only a syringe within outer
case, too bulky hard to read dose

so after comparing all australian syringes I know where I will put my money. Sure they have had to turn the company around but they have done exactly that. Strong partners, strong patents and poised for explosive growth. They have the correct part for the correct job. Diversification is their strengh and giving the medical industry what they want is what they do best. I believe UNI are a standout and at 0.29 are a bargain that will achieve multi bagger satus. They have achieved alot since subprime fallout when they were trading at 0.34-0.36 and following the charts will retest these levels very soon.
This is my opinion only please do your own research.